Last Updated: November 13, 2026

FENOLDOPAM MESYLATE - Generic Drug Details

Name: FENOLDOPAM MESYLATE Generic Launch, Drug Patent, and Exclusivity Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

What are the generic drug sources for fenoldopam mesylate and what is the scope of freedom to operate?

Fenoldopam mesylate is the generic ingredient in two branded drugs marketed by Hospira, Hikma, Luitpold, Sandoz, and Teva Parenteral, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

Summary for FENOLDOPAM MESYLATE

US Patents:	0
Tradenames:	2
Applicants:	5
NDAs:	5
Raw Ingredient (Bulk) Api Vendors:	63
Clinical Trials:	3
Patent Applications:	1,889
What excipients (inactive ingredients) are in FENOLDOPAM MESYLATE?	FENOLDOPAM MESYLATE excipients list
DailyMed Link:	FENOLDOPAM MESYLATE at DailyMed

Recent Clinical Trials for FENOLDOPAM MESYLATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Roma La Sapienza	Phase 4
Southeast Renal Research Institute	Phase 4
Southeast Renal Research Institute	Phase 2/Phase 3

See all FENOLDOPAM MESYLATE clinical trials

Medical Subject Heading (MeSH) Categories for FENOLDOPAM MESYLATE

Antihypertensive Agents
Dopamine Agonists
Vasodilator Agents

Anatomical Therapeutic Chemical (ATC) Classes for FENOLDOPAM MESYLATE

C01CA	Adrenergic and dopaminergic agents
C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01	CARDIAC THERAPY
C	Cardiovascular system

US Patents and Regulatory Information for FENOLDOPAM MESYLATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	CORLOPAM	fenoldopam mesylate	INJECTABLE;INJECTION	019922-001	Sep 23, 1997		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sandoz	FENOLDOPAM MESYLATE	fenoldopam mesylate	INJECTABLE;INJECTION	077155-001	Feb 15, 2005		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Luitpold	FENOLDOPAM MESYLATE	fenoldopam mesylate	INJECTABLE;INJECTION	076656-001	Dec 1, 2003		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.